Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®)
Condition(s):Nontraumatic Intracerebral Hemorrhage, Multiple LocalizedLast Updated:November 8, 2021Withdrawn
Hide Studies Not Open or Pending
Condition(s):Nontraumatic Intracerebral Hemorrhage, Multiple LocalizedLast Updated:November 8, 2021Withdrawn
Condition(s):Hypertension; PreeclampsiaLast Updated:August 25, 2020Terminated
Condition(s):Blood High Pressure; Aortic Dissection Type BLast Updated:December 23, 2016Unknown status
Condition(s):Hypertension During Pre-EclampsiaLast Updated:February 25, 2009Unknown status
Condition(s):Cerebral IschemiaLast Updated:May 22, 2014Withdrawn
Condition(s):Stroke, Acute; Cerebrovascular DisordersLast Updated:May 25, 2021Recruiting
Condition(s):General SurgeryLast Updated:August 26, 2020Completed
Condition(s):Acute Ischemic StrokeLast Updated:May 18, 2018Unknown status
Condition(s):Hypoxemic Respiratory Failure; Side Effect; Hypertensive EmergencyLast Updated:December 13, 2021Recruiting
Condition(s):Aging; Surgery; Blood Pressure; Anesthesia; Blood Loss, Surgical; Postoperative DeliriumLast Updated:August 16, 2016Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.